You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開能健康(300272.SZ)完成對原能生物增資
格隆匯 02-19 17:06

格隆匯 2 月 19日丨開能健康(300272.SZ)公佈,2020年12月18日,公司召開第五屆董事會第四次會議審議通過了《關於公司參與對原能生物增資暨關聯交易的議案》,公司董事會同意公司以貨幣方式投資4550萬元,認購上海原能細胞生物低温設備有限公司①(“原能生物”或“目標公司”)新增註冊資本1300萬元(持有其6.57%的股權)。公司與參與對原能生物增資的其他12家新增投資人一致同意對原能生物進行增資並共同簽署《增資協議》,以貨幣方式向原能生物合計投資3.4244元,合計認購原能生物新增註冊資本9784萬元。

根據《增資協議》約定,公司關於該項交易的相關事項完成情況如下:

1、2021年1月26日,公司按照協議約定,將4550萬元增資款匯入原能生物指定賬户,公司對該項增資所涉對應的目標公司註冊資本1300萬元已全部實繳到位。

2、2021年2月10日,原能生物完成該項投資相關的工商變更程序,其註冊資本由1億元增至1.9784億元;2021年2月18日,公司收到原能生物按照協議約定提供的出資證明、股東名冊及營業執照複印件等工商全套資料。

截至公吿披露日,開能健康直接持有原能生物 6.57%的股權;原能集團直接持有原能生物40.44%的股權;其餘12位新增投資人合計直接持有原能生物52.99%的股權。

2021年1月,原能集團因股權結構調整實施並完成了部分股東的減資,減資完成後,開能健康仍為原能集團持股第一的法人股東,開能健康持有原能集團的股權比例從15.1%調整為19.98%,為此開能健康通過原能集團間接持有原能生物8.08%的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account